Bromopyruvic acid

Bromopyruvic acid (also known as 3-bromopyruvic acid or 3-BrPA) is a halogenated derivative of pyruvic acid. It is a small, simple molecule that has been studied for its potential use in cancer treatment.

Etymology

The term "bromopyruvic acid" is derived from its chemical structure. The prefix "bromo-" refers to the presence of a bromine atom, while "pyruvic acid" refers to the pyruvate molecule, which is a key intermediate in several metabolic pathways.

Chemical Structure and Properties

Bromopyruvic acid is a halogenated derivative of pyruvic acid. It has a molecular formula of C3H3BrO3 and a molecular weight of 166.96 g/mol. The bromine atom in bromopyruvic acid is responsible for its potential as an alkylating agent.

Potential Use in Cancer Treatment

Bromopyruvic acid has been studied for its potential use in cancer treatment. It is thought to work by inhibiting the glycolysis pathway, which is often upregulated in cancer cells. This could potentially starve the cancer cells of energy, leading to their death.

Related Terms

• Pyruvic acid: The molecule from which bromopyruvic acid is derived.
• Glycolysis: The metabolic pathway that bromopyruvic acid is thought to inhibit.
• Alkylating agent: A type of drug that bromopyruvic acid could potentially act as.

See Also

• Cancer treatment
• Metabolic pathway
• Chemotherapy

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• 
  Bromopyruvic acid structural formula
• 
  Bromopyruvic acid 3D ball model